Literature DB >> 4191365

Antibody localization in horse, rabbit, and goat antilymphocyte sera.

N Kashiwagi, D Sherer, C M Townsend, R Jacobs, K Ono, B Kapur, T E Starzl.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1970        PMID： 4191365      PMCID： PMC2954763     

Source DB:  PubMed          Journal:  Surgery        ISSN： 0039-6060            Impact factor:   3.982


× No keyword cloud information.
  16 in total

1.  QUANTITATIVE DETERMINATION OF SERUM IMMUNOGLOBULINS IN ANTIBODY-AGAR PLATES.

Authors:  J L FAHEY; E M MCKELVEY
Journal:  J Immunol       Date:  1965-01       Impact factor: 5.422

2.  Prolongation of canine renal allograft survival with antilymphocytic serum.

Authors:  G J Clunie; B Nolan; K James; J G Watt; M F Woodruff
Journal:  Transplantation       Date:  1968-05       Impact factor: 4.939

3.  Antilymphoid sera in renal allotransplantation.

Authors:  R G Shorter; G A Hallenbeck; C Nava; H O'Kane; J H DeWeerd; W J Johnson
Journal:  Arch Surg       Date:  1968-08

4.  The effects of heterologous anti-thymocyte sera in mice. II. Quantitative evaluation of IgM, IgG, and their subunits in suppressing homograft reactions.

Authors:  M A Mandel; R Asofsky
Journal:  J Immunol       Date:  1968-06       Impact factor: 5.422

5.  [Antibody population in heterologous antilymphocyte serum of the rabbit].

Authors:  S Thierfelder; D Möller; M Eulitz; P Dörmer; I Kimura
Journal:  Klin Wochenschr       Date:  1968-03-01

6.  Studies on heterologous anti-lymphocyte serum in mice. II. Effect on the immune response.

Authors:  A P Monaco; M L Wood; J G Gray; P S Russell
Journal:  J Immunol       Date:  1966-02       Impact factor: 5.422

7.  Immunochemical studies on equine antibodies to human gamma-2-globulin.

Authors:  P Z Allen; S Sirisinha; J H Vaughan
Journal:  J Immunol       Date:  1965-11       Impact factor: 5.422

8.  Clinical use of antilymphoblast serum.

Authors:  J S Najarian; F K Merkel; G E Moore; R A Good; J C Aust
Journal:  Transplant Proc       Date:  1969-03       Impact factor: 1.066

9.  A trial with heterologous antilymphocyte globulin in man.

Authors:  T E Starzl; L Brettschneider; I Penn; R W Schmidt; P Bell; N Kashiwagi; C M Townsend; C W Putnam
Journal:  Transplant Proc       Date:  1969-03       Impact factor: 1.066

10.  The preparation and testing of horse antidog and antihuman antilymphoid plasma or serum and its protein fractions.

Authors:  Y Iwasaki; K A Porter; J R Amend; T L Marchioro; V Zühlke; T E Starzl
Journal:  Surg Gynecol Obstet       Date:  1967-01
View more
  5 in total

1.  Production of a Standardized Anti-Lymphocyte Globulin.

Authors:  C G Groth; N Kashiwagi; G E Moore; B Husberg; Chr Bjorken; Ch W Putnam; Th E Starzl
Journal:  Behring Inst Mitt       Date:  1972-09

2.  The nature of antiplatelet activity in antilymphoblast ALG--with special reference to cross-reacting antibody, immunochemical characterization, and Coombs' positive thrombocytopenia in ALG-treated renal recipients.

Authors:  H Amemiya; T Yokoyama; C W Putnam; M Torisu; T E Starzl
Journal:  Clin Exp Immunol       Date:  1972-03       Impact factor: 4.330

3.  The antigenic and immunosuppressive properties of normal and antilymphocytic equine IgG subfractions.

Authors:  R A Allardyce; N F Anderson; J P Vaerman; K James
Journal:  Clin Exp Immunol       Date:  1973-02       Impact factor: 4.330

4.  Clotting changes, including disseminated intravascular coagulation, during rapid renal-homograft rejection.

Authors:  T E Starzl; H J Boehmig; H Amemiya; C B Wilson; F J Dixon; G R Giles; K M Simpson; C G Halgrimson
Journal:  N Engl J Med       Date:  1970-08-20       Impact factor: 91.245

5.  The mechanism behind the effect of ALG on platelets in vivo.

Authors:  A Henricsson; B Husberg; S E Bergentz
Journal:  Clin Exp Immunol       Date:  1977-09       Impact factor: 4.330
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.